Clone:
REAL294
Type of antibody:
Releasable antibodies, Primary antibodies, Recombinant antibodies
Applications:
FC
Alternative names:
THY1, T25, Thy-1, Thy-1.2

Specifications for CD90.2 Antibody, anti-mouse,
REAlease
®

Overview

Clone REAL294 is an antibody fragment derived from the full mouse CD90.2 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity.
Clone REAL294 recognizes the mouse CD90 (Thy1.2) antigen which is expressed at high levels on thymocytes and peripheral T cells in lymphoid organs and blood as well as on retinal ganglion cells. Clone REAL294 reacts with the Thy1.2 alloantigen, which is a pan–T cell marker for the most common inbred mouse strain. These strains include BALB/c, DBA, CBA/J, C3H, C57BL/6, NZB/-, S3L and others. It does not cross-react with Thy1.1. CD90 is also expressed at lower levels on early hematopoietic stem cells in the bone marrow, on interepithelial cells (dendritic epidermal T cells) in skin, and on neurons.
The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.

Alternative names

THY1, T25, Thy-1, Thy-1.2

Detailed product information

Technical specifications

CloneREAL294
Clonalitymonoclonal
Isotype controlControl Antibody
Hostcell line
Type of antibodyReleasable antibodies, Primary antibodies, Recombinant antibodies
Speciesmouse
AntigenCD90.2
Alternative names of antigenTHY1, T25, Thy-1, Thy-1.2
Distribution of antigenendothelial cells, fibroblasts, leukocytes, lymphocytes, neurons, T cells, cancer stem cells, hematopoietic stem and progenitor cells, leukemia cells, mesenchymal stem cells, ES and iPS cells, thymocytes, brain